Dr Raj Mallipeddi is an award-winning consultant dermatological surgeon based in London who specialises in skin cancer, cosmetic dermatology and surgical dermatology alongside Mohs surgery, laser surgery, and photodynamic surgery. He practices privately for HCA Sydney Street Outpatient Centre, Dermatological Surgery, Laser Unit at Guy's Hospital Cancer Centre, and Bupa Cromwell Hospital. He also works for the Guy's and St Thomas' NHS Foundation Trust.
Dr Mallipeddi is well respected in the dermatology and skin cancer field, working in lead roles at top centres in the capital. He is the lead clinician for dermatological surgery and the laser unit at St John's Institute of Dermatology at Guy's Hospital Cancer Centre and was the lead consultant for skin cancer for his NHS trust, seeing referrals from all over the UK. Dr Mallipeddi studied at Imperial College in London where he was awarded an MBBS in 1997. During this time, he also completed an intercalated BSc (Hons) degree in psychology at University College London in 1994. Subsequently, he obtained a Doctor of Medicine higher research degree studying squamous cell carcinoma at King's College London from 2001 to 2003.
Dr Mallipeddi has been professionally recognised as well as by patients. He has been awarded the St John's Dermatological Society registrar prize, the Wooden Curette Award from the British Society for Dermatological Society and named by Marquis (American publisher of directories) as the Who's Who in Healthcare 2009-10. As well as being a highly-qualified professional, Dr Mallipeddi lectures nationally and internationally. He is also heavily involved in medical education as the national curriculum lead for Mohs and Advanced Dermatological Surgery.
He is also widely published, and a pioneer in his field for being one of the only UK doctors who has completed advanced training in Mohs micrographic surgery as certified by the American College of Mohs Surgery. He serves on numerous boards including chair of the UK Mohs micrographic service standards committee and was the past President of the British Society for Dermatological Surgery (2015-2017).
He was a member of the recent British Association of Dermatologists' (BAD) national guideline committees for basal cell carcinoma, squamous cell carcinoma and photodynamic therapy, alongside being an active member of the British Society for Dermatological Surgery (BSDS) and the British Association of Dermatologists (BAD). Furthermore he is currently President of the St John's Dermatological Society.